Biological variation of cardiovascular risk factors in patients with diabetes

HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2

(2012) A. Sugawara et al.   DIABETOLOGIA

HbA1c: how do we measure it and what does it mean?

(2011) Randie R Little et al.   Current Opinion in Endocrinology Diabetes and Obesity

Biological variability of glycated hemoglobin

(2010) Federica Braga et al.   CLINICA CHIMICA ACTA

Glucose variability is associated with intensive care unit mortality*

(2010) Jeroen Hermanides et al.   CRITICAL CARE MEDICINE

The Role of Blood Pressure Variability in the Development of Nephropathy in Type 1 Diabetes

(2010) E. S. Kilpatrick et al.   DIABETES CARE

Continuous Subcutaneous Insulin Infusion Is Better Than Multiple Daily Insulin Injections in Reducing Glucose Variability Only in Type 1 Diabetes With Good Metabolic Control

(2010) G. Lepore et al.   DIABETES CARE

The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: Retrospective long-term follow-up

(2010) Toshiko Takao et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

For debate.Glucose variability and diabetes complication risk: we need to know the answer

(2010) E. S. Kilpatrick et al.   DIABETIC MEDICINE

‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting

(2010) A. Ceriello et al.   DIABETIC MEDICINE

Glucose Variability; Does It Matter?

(2010) Sarah E. Siegelaar et al.   ENDOCRINE REVIEWS

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

(2010) Alastair JS Webb et al.   LANCET

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

(2010) Peter M Rothwell et al.   LANCET

A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes

(2009) J. Waden et al.   DIABETES

New and Improved Methods to Characterize Glycemic Variability Using Continuous Glucose Monitoring

(2009) David Rodbard   Diabetes Technology & Therapeutics

The Assessment of Glycemic Variability and Its Impact on Diabetes-Related Complications: An Overview

(2009) Christian Weber et al.   Diabetes Technology & Therapeutics

Reduced Daily Risk of Glycemic Variability: Comparison of Exenatide with Insulin Glargine

(2009) Anthony L. McCall et al.   Diabetes Technology & Therapeutics

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy

(2009) L. Monnier et al.   DIABETOLOGIA

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT

(2009) S. E. Siegelaar et al.   DIABETOLOGIA

Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

(2008) A. Ceriello et al.   DIABETES

Effect of Aging on A1C Levels in Individuals Without Diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004

(2008) L. N. Pani et al.   DIABETES CARE

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial

(2008) E. S. Kilpatrick et al.   DIABETES CARE

Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting

(2008) T. Sathyapalan et al.   DIABETIC MEDICINE

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine

(2008) D. Bruttomesso et al.   DIABETIC MEDICINE